150 related articles for article (PubMed ID: 25753145)
1. GATA3 expression in gestational trophoblastic tissues and tumours.
Mirkovic J; Elias K; Drapkin R; Barletta JA; Quade B; Hirsch MS
Histopathology; 2015 Nov; 67(5):636-44. PubMed ID: 25753145
[TBL] [Abstract][Full Text] [Related]
2. GATA-3 expression in trophoblastic tissues: an immunohistochemical study of 445 cases, including diagnostic utility.
Banet N; Gown AM; Shih IeM; Kay Li Q; Roden RB; Nucci MR; Cheng L; Przybycin CG; Nasseri-Nik N; Wu LS; Netto GJ; Ronnett BM; Vang R
Am J Surg Pathol; 2015 Jan; 39(1):101-8. PubMed ID: 25188865
[TBL] [Abstract][Full Text] [Related]
3. c-mos immunoreactivity aids in the diagnosis of gestational trophoblastic lesions.
Xue WC; Khoo US; Ngan HY; Chan KY; Ip PP; Tsao SW; Cheung AN
Int J Gynecol Pathol; 2004 Apr; 23(2):145-50. PubMed ID: 15084843
[TBL] [Abstract][Full Text] [Related]
4. Analysis of PD-L1 expression in trophoblastic tissues and tumors.
Lu B; Teng X; Fu G; Bao L; Tang J; Shi H; Lu W; Lu Y
Hum Pathol; 2019 Feb; 84():202-212. PubMed ID: 30339966
[TBL] [Abstract][Full Text] [Related]
5. Expression of melanoma cell adhesion molecule in intermediate trophoblast.
Shih IM; Kurman RJ
Lab Invest; 1996 Sep; 75(3):377-88. PubMed ID: 8804361
[TBL] [Abstract][Full Text] [Related]
6. GATA3 inhibits GCM1 activity and trophoblast cell invasion.
Chiu YH; Chen H
Sci Rep; 2016 Feb; 6():21630. PubMed ID: 26899996
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta.
Vegh GL; Selcuk Tuncer Z; Fulop V; Genest DR; Mok SC; Berkowitz RS
Gynecol Oncol; 1999 Nov; 75(2):248-53. PubMed ID: 10525381
[TBL] [Abstract][Full Text] [Related]
8. Expression pattern alterations of the serine protease HtrA1 in normal human placental tissues and in gestational trophoblastic diseases.
Marzioni D; Quaranta A; Lorenzi T; Morroni M; Crescimanno C; De Nictolis M; Toti P; Muzzonigro G; Baldi A; De Luca A; Castellucci M
Histol Histopathol; 2009 Oct; 24(10):1213-22. PubMed ID: 19688690
[TBL] [Abstract][Full Text] [Related]
9. SALL4 expression in gestational trophoblastic tumors: a useful tool to distinguish choriocarcinoma from placental site trophoblastic tumor and epithelioid trophoblastic tumor.
Stichelbout M; Devisme L; Franquet-Ansart H; Massardier J; Vinatier D; Renaud F; Kerdraon O
Hum Pathol; 2016 Aug; 54():121-6. PubMed ID: 27068524
[TBL] [Abstract][Full Text] [Related]
10. Expression of laminin receptor 1 in gestational trophoblastic diseases and normal placenta and its relationship with the development of postmolar tumors.
Kurdoglu M; Bayram I; Kolusari A; Erten R; Adali E; Bulut G; Yildizhan R; Kurdoglu Z; Kucukaydin Z; Sahin HG
Gynecol Oncol; 2009 Aug; 114(2):306-9. PubMed ID: 19481788
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemistry of choriocarcinoma: an aid in differential diagnosis and in elucidating pathogenesis.
Mao TL; Kurman RJ; Huang CC; Lin MC; Shih IeM
Am J Surg Pathol; 2007 Nov; 31(11):1726-32. PubMed ID: 18059230
[TBL] [Abstract][Full Text] [Related]
12. GATA3 Is a Sensitive and Specific Marker of Benign and Malignant Mesonephric Lesions in the Lower Female Genital Tract.
Howitt BE; Emori MM; Drapkin R; Gaspar C; Barletta JA; Nucci MR; McCluggage WG; Oliva E; Hirsch MS
Am J Surg Pathol; 2015 Oct; 39(10):1411-9. PubMed ID: 26135559
[TBL] [Abstract][Full Text] [Related]
13. PD-L1 Expression in Human Placentas and Gestational Trophoblastic Diseases.
Veras E; Kurman RJ; Wang TL; Shih IM
Int J Gynecol Pathol; 2017 Mar; 36(2):146-153. PubMed ID: 27362903
[TBL] [Abstract][Full Text] [Related]
14. Minichromosome maintenance protein 7 expression in gestational trophoblastic disease: correlation with Ki67, PCNA and clinicopathological parameters.
Xue WC; Khoo US; Ngan HY; Chan KY; Chiu PM; Tsao SW; Cheung AN
Histopathology; 2003 Nov; 43(5):485-90. PubMed ID: 14636275
[TBL] [Abstract][Full Text] [Related]
15. Expression pattern of the activating protein-1 family of transcription factors in gestational trophoblastic lesions.
Briese J; Sudahl S; Schulte HM; Löning T; Bamberger AM
Int J Gynecol Pathol; 2005 Jul; 24(3):265-70. PubMed ID: 15968203
[TBL] [Abstract][Full Text] [Related]
16. Endothelial nitric oxide synthase expression in gestational trophoblastic diseases.
Barut A; Harma M; Arikan I; Harma MI; Barut F
Int J Gynecol Cancer; 2010 Apr; 20(3):337-40. PubMed ID: 20375793
[TBL] [Abstract][Full Text] [Related]
17. A unifying concept of trophoblastic differentiation and malignancy defined by biomarker expression.
Lee Y; Kim KR; McKeon F; Yang A; Boyd TK; Crum CP; Parast MM
Hum Pathol; 2007 Jul; 38(7):1003-1013. PubMed ID: 17397906
[TBL] [Abstract][Full Text] [Related]
18. Methylation status and expression of E-cadherin and cadherin-11 in gestational trophoblastic diseases.
Xue WC; Feng HC; Tsao SW; Chan KY; Ngan HY; Chiu PM; Maccalman CD; Cheung AN
Int J Gynecol Cancer; 2003; 13(6):879-88. PubMed ID: 14675328
[TBL] [Abstract][Full Text] [Related]
19. Characterization of androgenetic/biparental mosaic/chimeric conceptions, including those with a molar component: morphology, p57 immnohistochemistry, molecular genotyping, and risk of persistent gestational trophoblastic disease.
Lewis GH; DeScipio C; Murphy KM; Haley L; Beierl K; Mosier S; Tandy S; Cohen DS; Lytwyn A; Elit L; Vang R; Ronnett BM
Int J Gynecol Pathol; 2013 Mar; 32(2):199-214. PubMed ID: 23370656
[TBL] [Abstract][Full Text] [Related]
20. Carcinoembryonic antigen and related molecules in normal and transformed trophoblast.
Vićovac Lj; Bozić M; Bojić-Trbojević Z; Golubović S
Placenta; 2007; 28(2-3):85-96. PubMed ID: 16574224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
